Discontinuing Antiseizure Medications Early Is Safe for Infants
⚠️ Pregnancy-related topic: medication, diet, and testing decisions must be made with your obstetrician and neurology team.
⚠️ Infant dosing/safety: medication and diet decisions for infants require individualized medical guidance.
Source: Epilepsia
Summary
Researchers studied the long-term safety of stopping antiseizure medications (ASMs) in newborns who had experienced acute provoked seizures. The study involved 284 neonates born between July 2015 and March 2018, who were followed until September 2024 at nine specialized centers in the U.S. The goal was to see how children fared if their ASMs were discontinued before they left the hospital compared to those who continued taking the medications.
The key findings showed that children who stopped taking ASMs after their seizures resolved had similar cognitive and developmental outcomes as those who continued the medication. At age 5, there was only a slight difference in IQ scores, and no difference in functional development or the occurrence of epilepsy later on. This suggests that many infants may not need to stay on ASMs for long periods after their seizures have stopped.
These results are important because they support the idea that stopping ASMs early can be safe for most newborns, potentially reducing unnecessary medication exposure. However, the study has limitations, such as the specific group of children studied and the need for further research to confirm these findings in different populations.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.
